FTC Challenges Illumina’s Proposed Acquisition of Cancer Detection Test Maker Grail

WSJ What's News
|

Automatic TRANSCRIPT

Federal trade commission has filed a lawsuit seeking to block gene sequencing company alumina from acquiring grail the developer of a blood test that promises to detect cancer early. The ftc says the plan seven point one billion dollar deal would diminish innovation because test developers have no choice but to use aluminum instruments the commission alleges that the company could raise the prices at charges to growls competitors and impede their research and development efforts. The case sets up a major test for us antitrust enforcement because the proposed deal is a vertical merger of companies. That don't compete head to head. The only other litigated challenge to a vertical merger in the past forty years was the justice. Department's twenty seventeen case against at and t.'s. Acquisition of time warner which the government

Coming up next